文献速递眼底病与葡萄膜炎

抗坏血酸通过DNA羟甲基化抑制视网膜色素上皮细胞VEGF表达

Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

本研究探讨抗坏血酸经DNA羟甲基化对RPE细胞VEGF表达的影响。在ARPE-19细胞中,50 μM抗坏血酸促进5hmC生成并改变全基因组5hmC谱,VEGFA为下调最显著基因之一,该抑制不依赖HIF-1α而与基因体5hmC增加相关;原代人胎儿RPE细胞及Gulo-/-小鼠实验验证了VEGF转录、分泌及眼内水平的下降。结论提示抗坏血酸可能参与AMD等疾病的预防或治疗。

要点

  • 50 μM抗坏血酸促进ARPE-19细胞5hmC生成并改变全基因组5hmC谱。
  • 抗坏血酸下调VEGFA不依赖HIF-1α,与基因体5hmC增加相关。
  • 饮食添加抗坏血酸使Gulo-/-小鼠RPE/脉络膜及玻璃体VEGF水平下降。

核心结论

  • 抗坏血酸可能通过DNA羟甲基化抑制RPE细胞VEGF表达,可能参与AMD等疾病的预防或治疗。

研究设计与样本

  • 基础研究:以ARPE-19细胞行dot-blot与羟甲基化DNA免疫沉淀测序评估DNA羟甲基化,RNA-seq分析转录组。
  • 以定量RT-PCR和ELISA检测培养细胞VEGF转录与分泌,并用原代人胎儿RPE细胞和RPE-J细胞验证。
  • 以ELISA测定Gulo-/-小鼠玻璃体VEGF,该小鼠与人类一样不能从头合成抗坏血酸。

主要发现

  • 50 μM抗坏血酸处理ARPE-19细胞促进5hmC生成并改变全基因组5hmC谱。
  • 抗坏血酸引起转录组显著改变,3186个差异转录本中69.3%与启动子或基因体5hmC改变相关。
  • VEGFA是下调最显著的基因之一,抗坏血酸对VEGF的抑制不依赖HIF-1α,而与基因体5hmC增加相关。
  • 在原代人胎儿RPE细胞中验证了抗坏血酸降低VEGF转录和分泌。
  • 饮食添加抗坏血酸使Gulo-/-小鼠RPE/脉络膜和玻璃体VEGF水平降低。

临床怎么用

  • 原代人胎儿RPE细胞验证了抗坏血酸降低VEGF转录与分泌。
  • Gulo-/-小鼠饮食添加抗坏血酸后RPE/脉络膜及玻璃体VEGF水平下降。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the impact of ascorbate, via DNA hydroxymethylation, on VEGF expression in retinal pigment epithelial (RPE) cells. METHODS: Dot-blot and hydroxymethylated DNA immunoprecipitation sequencing were applied to evaluate the impact of ascorbate on DNA hydroxymethylation in ARPE-19 cells. RNA sequencing (RNA-seq) was carried out to analyze the transcriptome. Quantitative RT-PCR and ELISA were conducted to examine the transcription and secretion of VEGF from cultured cells. Primary human fetal RPE cells and RPE-J cells were used to verify the effect of ascorbate on VEGF expression. ELISA was used to measure VEGF in the vitreous humor of Gulo-/- mice, which, like humans, cannot synthesize ascorbate de novo. RESULTS: Treatment with ascorbate (50 μM) promoted 5-hydroxymethycytosine (5hmC) generation and changed the genome-wide profiles of 5hmC in ARPE-19 cells. Ascorbate also caused a dramatic shift in the transcriptome-3186 differential transcripts, of which 69.3% are correlated with altered 5hmC in promoters or gene bodies. One of the most downregulated genes was VEGFA, which encodes the VEGF protein. The suppression of VEGF by ascorbate is independent of hypoxia-inducible factor 1-alpha (HIF-1α) but correlates with increased 5hmC in the gene body. The decreased transcription and secretion of VEGF by ascorbate were verified in primary human fetal RPE cells. Furthermore, adding ascorbate in the diet for Gulo-/- mice resulted in decreased levels of VEGF in the RPE/choroid and vitreous humor. CONCLUSIONS: Ascorbate inhibits VEGF expression in RPE cells likely via DNA hydroxymethylation. Thus, ascorbate could be implicated in the prevention or treatment of diseases such as age-related macular degeneration (AMD).

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Sant DW, Camarena V, Mustafi S, et al. Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells. Invest Ophthalmol Vis Sci. 2018. PMID: 30025088. doi:10.1167/iovs.18-24101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。